Article Information
History
- February 9, 2022.
Article Versions
- Version 1 (September 29, 2021 - 08:37).
- Version 2 (October 8, 2021 - 07:13).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Naba Al-Sari1,
- Svetlana Kutuzova2,
- Tommi Suvitaival1,
- Peter Henriksen1,
- Flemming Pociot1,3,
- Peter Rossing1,3,*,
- Douglas McCloskey2,* and
- Cristina Legido-Quigley1,4,*
- 1Steno Diabetes Center Copenhagen, Denmark
- 2Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
- 3Dept. of Clinical Medicine, University of Copenhagen, Denmark
- 4Institute of Pharmaceutical Science, King’s College London, UK
- ↵*Correspondences: Cristina Legido-Quigley: cristina.legido.quigley{at}regionh.dk; Niels Steensens Vej 2-4, DK-2820Gentofte, Denmark. Phone number: +004530913083., Douglas McCloskey: domccl{at}biosustain.dtu.dk; Anker Engelunds Vej Building 220, DK-2800 Lyngby, Denmark. Phone number: +004593511957., Peter Rossing: peter.rossing{at}regionh.dk; Niels Steensens Vej 2-4, DK-2820 Gentofte, Denmark. Phone number: +004530913383.
Posted February 09, 2022.
Precision Diagnostic Approach to Predict 5-year Risk for Microvascular Complications in Type 1 Diabetes
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos